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• Hydromorphone misuse and illicit use have become a growing public health 
challenge globally. 1
• In recent years, there has been a significant increase in the emergency 
department (ED) administration of hydromorphone relative to other opioids.
• Although hydromorphone is an effective analgesic, its use has been commonly 
implicated in adverse drug events, medication errors, and over usage.2
• Since hydromorphone adverse events are dose-dependent, multimodal opioid-
sparing strategies that reduce its use are desirable.3
Homestead Hospital’s ED is the only one within 18 miles of its location, treating 
more than 90,000 patients each year. As a high volume of patients present with 
conditions that involve pain management, we aim to evaluate the ED’s current usage 
of hydromorphone.
Study Design: 
A  retrospective, single center, descriptive study was conducted reviewing 
electronic health records of patients who received hydromorphone in the ED.
Sample: 
100 subjects 
Inclusion Criteria : 
Patients 18 years old or older treated with hydromorphone in the ED from 
January 1 to June 30,  2019.
Exclusion Criteria: 
• Patients less than 18 years old
• Hospice and cancer patients
• Patients hospitalized outside the aforementioned date range 
Procedure: 
• A computerized report was generated identifying patients who received 
hydromorphone in the ED from January 1 to June 30, 2019. 
• One hundred patients were then randomly selected for inclusion in the study.
• Data pertinent to the following were extracted through a retrospective 
electronic chart review: patient identifier, age, gender, dose of 
hydromorphone, route of administration, indication/chief complaint, naloxone 
use, adverse drug reactions(ADRs), and additional analgesics, if any.
Statistical Analysis:
Descriptive statistics including frequencies, percentages, and measures of central 
tendency were generated.
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Based on the prescription patterns identified, a protocol addressing alternatives to 
hydromorphone based on indications for use will be written and put into practice 
thereafter. Data collection will be necessary after implementation of such protocol 
to determine its impact on the prescribing patterns of hydromorphone.
Variable N (%)
Gender (%)
Female 61 (61%)
Male 39 (39%)
Age
Median [IQR] 46 [34.5 – 60]
• Over usage and misuse of hydromorphone have the potential for abuse and 
increased side effects.  
• These results revealed the need for the implementation of pain management 
services and opioid stewardship programs involving pharmacists.
• Limitations: single-center study with a short data collection period, small sample 
size, evaluation of only ED patients, and retrospective data collection that 
depended on what was documented in the electronic medical record.
• No ADRs or naloxone administration were reported. 
• Non-opioid medications were prescribed concomitantly with hydromorphone in 
only 34% of the population sample.
• Substance abuse was documented on 3 subjects.
Variable N (%)
Dose (mg)
0.2 2 (2%)
0.5 42 (42%)
1 55 (55%)
2 1 (1%)
Administration Route
Intravenous 92 (92%)
Intramuscular 8 (8%)
Table 1. Patient Demographics a (N=100)
Table 2. Dosage and Administration Route of Hydromorphone (N=100)
Figure 1. Hydromorphone Usage by Indication
a IQR= interquartile range
